Hep C Treatment Response Predicted by Gene and Hep C Subtype | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Hep C Drug Alert: New Meds Don't Mix with Statins!

Back to News Homepage
Next

Advancement in Liver Cell Regeneration

Hep C Treatment Response Predicted by Gene and Hep C Subtype

The Editors at Hepatitis Central
March 8, 2012

Print this page

In addition to carrying the IL28B gene, Spanish researchers have found that in HIV co-infected patients, a subtype of Hepatitis C genotype 1 fares better than another.

Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients

Michael Carter

Published: 01 March 2012

Hepatitis C treatment responses in patients co-infected with HIV are better in patients infected with hepatitis C subtype-1b than 1a, according to Spanish research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The research also showed that the presence of the IL28B gene influenced treatment responses.

“We noticed that on treatment responses and SVR [sustained virological response] rates were uniformly worse in HCV-1a as compared to HCV-1b patients,” comment the authors.

“Another important finding of our study was that early viral kinetics in HCV-1 patients was significantly influenced by…IL28B.”

Continue reading this entire article:

http://www.aidsmap.com/Hepatitis-C-subtype-1b-and-carriage-of-IL28B-gene-associated-with-improved-treatment-responses-in-HIV-co-infected-patients/page/2273761/

No Comments - be the first!
Share
Share
Previous

Hep C Drug Alert: New Meds Don't Mix with Statins!

Back to News Homepage
Next

Advancement in Liver Cell Regeneration

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.